Microbiome-directed therapies in oncology: from animal models to clinical implementation
Authors:
- Karolina Skonieczna-ŻydeckaKSKarolina Skonieczna-Żydecka
- Maria MarliczMMMaria Marlicz
- Mariusz KaczmarczykMKMariusz Kaczmarczyk
- Igor ŁoniewskiIŁIgor Łoniewski
- Patrycja BolukPBPatrycja Boluk
- Natalia Ekstedt-BiskotNENatalia Ekstedt-Biskot
- Krzysztof KutrzubaKKKrzysztof Kutrzuba
- Wojciech MarliczWojciech Marlicz
Open Access
- 8 October 2026
- journal article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 83
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- Experiences and preferences about information on treatment-related side effects among patients with early breast cancerThe Breast, 2025
- Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasisImmunity, Inflammation and Disease, 2024
- Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)The Breast, 2023
- Gut Microbiome Dysbiosis in Patients with Endometrial Cancer vs. Healthy Controls Based on 16S rRNA Gene SequencingCurrent Microbiology, 2023
- Akkermansia muciniphila and its outer membrane protein Amuc_1100 prophylactically attenuate 5-fluorouracil-induced intestinal mucositisBiochemical and Biophysical Research Communications, 2022
- Chemotherapy induced gastrointestinal toxicities2022
- Treatment-Related Complications of Systemic Therapy and RadiotherapyJAMA Oncology, 2019
- Specific properties of probiotic strains: relevance and benefits for the hostEPMA Journal, 2018
- Mouse models for human intestinal microbiota research: a critical evaluationCellular and Molecular Life Sciences, 2017
- Probiotics: definition, scope and mechanisms of actionBest Practice & Research Clinical Gastroenterology, 2016